Trending

Ethereum risks 35% drop by June with ETH price confirming ‘ascending triangle’ fakeout May 27, 2022

Concert Pharmaceuticals Inc (NASDAQ: CNCE) looks to ride another Wave higher May 27, 2022

Avadel Pharmaceuticals (NASDAQ: AVDL) up on over 5 million premarket shares May 27, 2022

(NASDAQ:SIGA) up more than 14% today as traders continue to push. Chart May 27, 2022

(NASDAQ:RDBX) UPDATE Shares are soaring again today on heavy volume, $8.35 more than 22,000 trades May 27, 2022

Next

Prev

$195.19 $3.79 1.98%

$149.64 $5.86 4.08%

$2,302.93 $81.38 3.66%

$759.63 $51.90 7.33%

$2,255.98 $90.06 4.16%

Home Tag Nkarta Therapeutics Inc.

Tag: Nkarta Therapeutics Inc.

Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell Programs

by 24/7 MarketNews Admin

NKX101 – 3 of 5 patients with relapsed / refractory AML treated with a three-dose regimen consisting of 1B or ...